IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
about
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Initial immunopathogenesis of multiple sclerosis: innate immune response.Toll-Like Receptor Pathways in Autoimmune Diseases.Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
P2860
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@en
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@nl
type
label
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@en
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@nl
prefLabel
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@en
IFN-β therapy modulates B-cell ...... n multiple sclerosis patients.
@nl
P2093
P2860
P50
P356
P1476
IFN-β therapy modulates B-cell ...... in multiple sclerosis patients
@en
P2093
Elena Giacomini
Eliana Marina Coccia
Giovanni Ristori
Marco Salvetti
Valeria Riccieri
Viviana Annibali
P2860
P304
P356
10.1002/EJI.201243212
P407
P577
2013-05-28T00:00:00Z